ÂÜÀòÂÒÂ×

Thomas De Beer is the current CEO and co-founder of RheaVita, a company that focuses on developing treatments for rare diseases. Thomas has also been a professor at Ghent University since 2010. Prior to their current positions, they worked as a post doc at the Faculty of Pharmaceutical Sciences at the University of Copenhagen and as a PhD student at Ghent University.

Some individuals on their team include Jos Corver - CTO, Jan Van Hauwermeiren - Business Development Director, and Veerle Bultinck - Office Manager.